Cross over placebo control trial of dilazep in beta-thalassemia/hemoglobin E patients

• Main Authors: Nisarat Opartkiattikul, Sathien Sukpanichnant, Yoshinori Funahara, Akinobu Sumiyoshi, Wanchai Wanachiwanawin, Noriyuki Tatsumi, Suthat Fucharoen
• Other Authors: Mahidol University
• Format: Article
• Published: 2018
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/25634

An attempt was made to find better symptomatic treatment for beta-thalassemia/hemoglobin E (β-thal/Hb E) patients in order to reduce their blood demand. Oral administration of dilazep was prescribed for these patients and a clinical trial was conducted over a 2-year period as a cross over placebo co...